possessed different patterns of drug resistance from parental viruses. Mutational analyses were performed by PCR to substantiate these observations, which were also confirmed by direct sequencing of single strands of DNA segments, obtained from plaque-purified viruses. These studies indicate that viral recombination had occurred, and establish a theoretical basis on which to conclude that the acquisition of multiple drug resistance on the part of HIV-1 may be related to its ability to promote cell fusion.
Mutations in the human immunodeficiency virus type 1 (HIV-1) poI gene can yield resistance to antiviral drugs (Larder & Kemp, 1989; Gu et al., 1992) . HIV-1 variants that possess a drug resistance phenotype can be isolated from patients undergoing prolonged antiviral chemotherapy Rooke et al., 1989) and can be selected in vitro by culture passage in the presence of increasing concentrations of drugs (Gao et al., 1992; Larder et al., 1991) . HIV-1 resistance against a wide array of drugs has been identified (Eron et al., 1993; St Clair et al., 1991) . A recent report showed that viral recombination may account for the acquisition of different resistance-conferring mutations against a single drug (Kellam & Larder, 1995) . The possibility that genetic recombination might lead to resistance against several drugs should also be considered.
Sequence data suggest that recombination among HIV-1 env gene loci can occur in vivo (Groenink et al., 1992) . Infectious virus has been generated following transfection of two exogenous segments of HIV-1 DNA into HIV-l-susceptible cells (Srinivasan et al., 1989) . Fusion of cells carrying envelope-defective non-infectious particles with cells unable to generate RT activity * Author for correspondence. Fax + 1 514 340 7537. also yielded infectious progeny as a consequence of recombination (Boulerice et al., 1991) .
Cell fusion, the result of the HIV-1 syncytium-inducing phenotype (SI), is mediated by interactions between HIV-1 envelope proteins (gp41 and gp120/160) on infected cells and CD4 receptors on either infected or uninfected cells, and is commonly observed in HIV-1-infected cultures (Tersmette et al., 1988; Boucher et al., 1992) . Although such syncytia are not generally found in the blood of HIV-l-infected individuals, new studies indicate that they may exist in lymph nodes and other lymphoid tissues in which HIV-1 infection is extensive (Pantaleo et al., 1993) . Cell fusion induced by HIV-1 usually leads to cell death in culture, may contribute to the depletion of CD4 + T lymphocytes in AIDS patients (Lifson et al., 1986; Sodroski et al., 1986) and may constitute an important means of virus transmission within the host.
The present work began with attempts to fuse HIV-1-infected T lymphocytes that carried recombinant HIV-1 viruses resistant to different drugs, in the hope of demonstrating viral recombination and establishment of dual drug resistance. These efforts were unsuccessful due to non-viability of the hybrid cells generated. HIV-1 can also infect CD4 + cells of monocyte/macrophage lineage, which may be an important reservoir for HIV-1 persistence and dissemination (McInnes & Rennick, 0001-3386 © 1995 SGM Short communication Roy & Wainberg, 1988) . The possibility of such interactions in vivo leading to viral recombination cannot be excluded, particularly since interleukin 4 and interferon ~ can both induce monocytic giant cell formation (McInnes & Rennick, 1988) .
Growth of the MT4 human T cell line and the U937 line of human monocytic cells as suspension cultures (3 x 10 ~ to 5 x 105 cells/well in RPMI 1640 medium) has been described (Bour et al., 1991) . The HIV-lmB laboratory strain of HIV-1 was kindly provided by Dr R. C. Gallo (NIH, Bethesda, Md., USA). AZT (3'-azido-3'-deoxythymidine) was obtained from Burroughs-Wellcome and 3TC (2',3'-dideoxy-3'-thiacytidine) was provided by Glaxo. Methods used to infect MT4 cells with wild-type and recombinant viruses have been described (Gu et al., , 1994 , as have procedures to generate HIV-1 variants and recombinants resistant to AZT, 3TC and other drugs (Gu et al., , 1994 . This study was performed with recombinant HIV-1 variants that displayed resistance to either AZT or 3TC but not both. The former virus contained previously described mutations at positions 70 (Lys ~ Arg) and 215 (Thr ~ Tyr) in the HIV-1 pol gene (Larder & Kemp, 1989) , while the latter contained a Met ---, Val substitution at codon 184 Tisdale et al., 1993) . U937 cells (3 x 105) were co-cultivated with MT4 cells (6 x 105) that had been previously infected with either wild-type HIV-1 or HIV-1 variants that were resistant to AZT or 3TC at a ratio of 1:2. The mixtures were maintained as suspensions (5 x 105 cells/ml). After 2 weeks, the MT4 ceils had disappeared due to virusinduced cell death. This was confirmed by the absence of cells reactive with OKT3 monoclonal antibodies, which recognize the CD3 marker present on all lymphocytes [as determined by indirect immunofluorescence assay (IFA) and flow cytometry]. After 5 weeks, over 95 % of the surviving U937 cells were positive for virus p24 antigen by IFA. Genomic identification of mutations at codons 70, 215 and 184 was performed by selective PCR, as described below.
Briefly, U937 cells (total of 106) infected with wild-type HIV-lmB or with either AZT-or 3TC-resistant viruses were co-incubated at a ratio of 1:1. The mixture was washed twice by centrifugation in serum-free RPMI 1640 medium. The cell pellets were then gently resuspended in 0'7 ml of prewarmed PEG 1500 and diluted 1:1 into medium for 60 s using large-bore transfer pipettes. A double volume of medium was then added to the mixture to dilute the PEG 1500. The cells were washed by centrifugation, resuspended and aliquoted in fresh medium into a 6-well plate. The appearance of large polymorphonuclear cells indicated that fusion had occurred. Giant cells were harvested by micromanipulation, under an inverted microscope, using extra-small- HIV-1IIIB 0"03+0"002 0"7+0"08 0"5 ±0"06 AZT-R/IIIB 2"5_+0"03 0"6_+0"12 0"6+0"16 3TC-R/IIIB 0'04+0"001 910+81 0"45±0"06 Hybrid l 0"08_+0.004 752_+62 0"7_+0. t These results were determined using progeny of singly plaquepurified viruses of each hybrid. AZT-R and 3TC-R designate recombinant viruses of HIV-1 m8 origin which are resistant to AZT and 3TC, respectively.
bore Pasteur pipettes and seeded individually into a 96-well plate to which fresh, uninfected MT4 cells (3 x 104 cells/well) had been placed. Once syncytia appeared in these MT4 co-cultures, cell suspensions were transferred to culture flasks (5 mt medium; 5 x 105 cells/ml) for virus amplification in the absence of drug. Clarified culture fluids were used as a source of virus for drug sensitivity assays and in some cases viruses were plaque-purified and cloned for genomic analysis as described . Similar procedures were utilized in attempts to establish viable hybrids of MT4 cells that had been infected with drug-resistant viruses of HIV-1. However, these efforts were unsuccessful and no viable giant cells were obtained.
Large polymorphonuclear cells were seen within 1-2 rain of addition of PEG 1500 to infected U937 cells. Approximately 200 such cells were selected for co-culture with MT4 cells. Of these 200 co-cultures, about 190 produced virus progeny of which 15 yielded virus that seemed doubly resistant or doubly sensitive to both AZT and 3TC on initial screening. Nine of the latter were chosen for genetic analysis and produced detectable virus within 4-6 days, as demonstrated by the appearance of syncytia in the MT4 cultures, RT activity in culture fluids and the presence of virus p24 antigen by IFA.
To determine the drug resistance phenotypes of these variants, sensitivity to ant±viral drugs was assessed on MT4 cells by monitoring production of viral p24 antigen in culture fluids. The results (Table 1) show that the viruses generated in five of nine cases by this method (hybrids 1, 2, 4, 6 and 7) possessed resistance to either AZT or 3TC but not both. In two instances (progeny of hybrids 3 and 9), the viruses were 40-50-fold more resistant to AZT and 90-120-fold more resistant to 3TC, in comparison with wild-type HIV-lmw In the case of hybrid 5, a degree of sensitivity to AZT was seen against a background of resistance to 3TC. The progeny of hybrid 8 were apparently sensitive to both AZT and 3TC. The parental viruses employed in this work possessed resistance phenotypes of about the same magnitude for these drugs. As an additional control, we also studied the profiles of these viruses to 2',Y-dideoxy-3'-didehydrothymidine (d4T) and found that all viruses were sensitive to this drug. We also observed that the doubly resistant viruses were as infectious for MT4 cells and peripheral blood mononuclear cells as wild-type viruses or those possessing resistance to a single drug only, as indicated by levels of RT activity in culture fluids (data not shown).
To determine whether mutations associated with resistance against AZT or 3TC could be detected in viruses derived from our hybrid cells, some of the viruses were plaque-purified in the MT4 cell line. Cellular DNA was extracted and a double amplification procedure using the RTO 1-RTO2 primer pair, described in Table 2 , was used to amplify a DNA fragment containing the complete RT coding sequence by nested PCR (Gu et al., 1994) . The DNA products thus generated were subjected to further specific amplification using the RTO1 and 70W or 70G, 184U and 184W or 184G, and 184U and 215W or 215T primer pairs to discriminate between the wild-type codon and mutations at positions 70, 184 and 215, respectively. The former two mutations are associated with resistance to AZT (Larder & Kemp, 1989) , while the latter confers resistance against 2',3'-dideoxyinosine (ddI), 2',3'-dideoxycytidine (ddC) and 3TC Tisdale et at., 1993) . DNA products of PCR were separated by electrophoresis on agarose gels and t Two out of five plaque-purified viruses possessed all three of these mutations.
Three out of five plaque-purified viruses possessed both M184V and T215Y substitutions.
§ One plaque-purified virus possessed wild-type codons at each of the 70, 215 and 184 sites.
visualized by ethidium bromide staining. Viruses from five different plaques were assayed in each case (Table 3) .
To confirm the results of our PCR analysis, and to rule out the possibility that we had merely detected mutations along separate proviral DNA strands, a 1742 base segment of the pol gene of some of these viruses, containing the complete RT coding region, was cloned into M13mpl9 and sequenced as described (Gu et al., 1994) . Sequencing studies confirmed that the parental AZT-resistant variant contained mutations at codons 70 (Lys ~ Arg) and 215 (Thr ~ Tyr), while the parental 3TC-resistant virus was mutated at codon 184 (Met Val). Mutations at codons 70 and 215 were also detected in samples derived from hybrids 2, 6 and 7, while variants derived from hybrids 1 and 4 were mutated at codon 184 only. In the case of hybrids 3 and 9, all three mutations were present in each of four plaque-purified viruses, suggesting that two recombination events may have occurred in this instance. Three of the five plaquepurified viruses derived from hybrid 5 contained both the 215 and 184 mutations. One of the plaque-purified viruses derived from hybrid 8 possessed both a wild-type genotype and phenotype.
To rule out the possibility that genetic recombination had occurred during the nested PCR, varying proportions of cellular DNA from infected cells, containing either the 70 and 215 mutations or the 184 mutation, were mixed and studied. As an additional control, we included cellular DNA from cells that contained the K65R mutation, responsible for resistance to ddC and 3TC (Gu et al., 1994) . In no instance was PCR-induced recombination observed.
In conclusion, we have generated HIV-1 variants that contained distinct mutations associated with resistance to AZT (codons 70 and 215) and 3TC (codon 184) by fusion of cells infected with different virus clones. This combination of mutation sites is not the same as that which causes phenotypic restoration of AZT sensitivity (i.e. codons 184 and 215 or 41, 184 and 215; Tisdale et al., 1993; Boucher et al., 1993) . Indeed, certain viruses derived from hybrid cell 5 possessed mutations at codons 184 and 215 and appeared to have renewed sensitivity to AZT against a background of 3TC resistance, consistent with previous results (Tisdale et al., 1993) . The progeny of hybrid 8 possessed wild-type genotype and phenotype. The period between PEG-induced cell fusion and generation of doubly resistant progeny was relatively short, possibly arguing for a two-stage process. Initially, particles produced by fused cells may have contained heterozygous RNA molecules within the same virion. This complementation may have been followed by virus replication; a more detailed mechanistic analysis will require knowing how many copies of proviral DNA were present in each of the cell clones.
A key issue in these experiments was to rule out the possibility that mixed virus populations may have been produced as opposed to recombinants. First, the degree of resistance generated against 3TC and AZT by the presumed hybrid cells 3 and 5 (Table 1) is consistent with the notion that individual mutations along a single proviral DNA chain were responsible. This is substantiated by our sequencing of individual cloned segments of proviral DNA.
In view of the fact that the development of HIV-1 drug resistance Rooke et al., 1989) and the SI phenotype (Boucher et al., 1992; Tersmette et aL, 1988) are independently associated with clinical progression, it is tempting to hypothesize that the fusion of HIV-l-infected cells contributes to genetic recombination in either of two ways. First, fusion and genomic recombination could result in the acquisition of double or multiple resistance, as hypothesized here. Second, such events may play a role in the acquisition by a single viral quasispecies of multiple mutations that act in synergy to confer high level resistance to drugs such as AZT, as recently demonstrated through a mixed infection system (Kellam & Larder, 1995) .
Finally, it is possible that these results might not have been obtained had AZT-resistant viruses with a 41 L215Y background been employed rather than the 70R215Y recombinants that we employed. First, the 70R215Y combination has only marginal insensitivity to AZT (Kellam et al., 1994) . If we had employed the 41L215Y combination instead, then recombination with 184V might have resulted in restoration of susceptibility to AZT. Notwithstanding these limitations, however, it is apparent from our data that cell fusion leading to viral recombination should be considered as a potential mechanism responsible for high level or multiple drug resistance.
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